Loading clinical trials...
Loading clinical trials...
A Randomized Comparative Phase I Study to Evaluate and to Compare the Safety and Immunogenicity of a Transcutaneous Mode of Administration of a Licensed Tetanus/Influenza Vaccine to the Conventional Intramuscular Route of Vaccine Administration in Healthy Volunteers and HIV-infected Patients
Conditions
Interventions
Transcutaneous mode of administration
Intramuscular mode of administration
Locations
2
Germany
Hospital of the Johann Wolfgang Goethe-University Frankfurt am Main
Frankfurt, Frankfurt Am Main, Germany
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Start Date
October 1, 2005
Primary Completion Date
February 1, 2006
Completion Date
September 1, 2009
Last Updated
November 25, 2009
NCT07310264
NCT04929028
NCT06342713
NCT07472361
NCT06649110
NCT04142047
Lead Sponsor
Objectif Recherche Vaccins SIDA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions